Leidos receives extension on LAMS system for additional Artemis missions
Huntsville, Ala. (Oct. 3, 2023) – Leidos announced today that it received a contract award from NASA extending production of the company’s Laser Air Monitoring System (LAMS) for Artemis IV and V missions. The follow-on contract, worth $14.1 million, was awarded in August and will extend for a period of 19 months. The total contract value of $37.8 million includes the completed fabrication of LAMS for the Artemis III, IV and V missions to the moon.
This will be an important part of the ORION spacecraft’s Environmental Controls and Life Support Systems (ECLSS). Each mission will require four individual LAMS units, as well as one spare unit.
“This extension reaffirms the importance of LAMS to the ORION Program and our commitment to NASA’s mission,” said Leidos Space Division Manager for the Dynetics Group Robert Wright. “This is a long journey of product research, development and improvement of the particular units in ECLSS, which will support protecting astronaut life. We are relying on the success of our previous work and feedback from NASA to ensure these systems are both resilient and effective.”
“We have a talented team of committed engineers working on this exciting NASA program, and they are ready to build and deliver nine LAMS units for both Artemis IV and V missions," said Trista Niemann, Leidos LAMS Program Manager.
LAMS is the first air monitor for a human spacecraft to use this type of technology.
Work on the contract will take place in Huntsville, Alabama. Testing is scheduled to take place at various NASA sites before delivery to Kennedy Space Center in Florida.
Leidos is a Fortune 500® technology, engineering, and science solutions and services leader working to solve the world’s toughest challenges in the defense, intelligence, civil, and health markets. The company’s 46,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $14.4 billion for the fiscal year ended December 30, 2022. For more information, visit www.leidos.com.
Certain statements in this announcement constitute “forward-looking statements” within the meaning of the rules and regulations of the U.S. Securities and Exchange Commission (SEC). These statements are based on management’s current beliefs and expectations and are subject to significant risks and uncertainties. These statements are not guarantees of future results or occurrences. A number of factors could cause our actual results, performance, achievements, or industry results to be different from the results, performance, or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, the “Risk Factors” set forth in Leidos’ Annual Report on Form 10-K for the fiscal year ended December 30, 2022, and other such filings that Leidos makes with the SEC from time to time. Readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. Leidos does not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statements were made.